期刊文献+

心力衰竭患者应用培哚普利与卡托普利的首剂低血压反应比较 被引量:4

First-dose hypotension response to perindopril and captopril in patients with chronic heart failure
原文传递
导出
摘要 目的 观察心力衰竭 (心衰 )患者对小剂量血管紧张素转换酶抑制剂的首剂低血压反应。方法 采用多中心、随机、平行对照的研究 ,16 7例 (5 9~ 91岁 )的心衰患者 (左室射血分数≤4 0 % )随机接受 2mg的培哚普利 (89例 )或 6 2 5mg的卡托普利 (78例 )治疗。应用动态血压监测用药前 2h及用药后 8h的血压改变。结果 以平均动脉压下降≥ 2 0mmHg(1mmHg =0 133kPa)和收缩压 <90mmHg定义为首剂低血压反应 ,培哚普利组的发生率明显低于卡托普利组 (10 1%与2 0 5 % ,P <0 0 5 )。培哚普利组最大的收缩压下降明显小于卡托普利组 [(19 2± 15 7)mmHg与(2 4 9± 17 6 )mmHg ,P =0 0 2 6 ]。所有的首剂低血压反应均无症状 ,仅通过动态血压监测发现。首剂低血压的发生与既往心肌梗死病史有关 ,合并陈旧性心肌梗死的心衰患者首剂低血压的发生率高于无心肌梗死病史的心衰组 (34 8%与 12 2 % ,P <0 0 1)。结论 培哚普利 2mg应用于心衰患者的首剂低血压发生率较低 ,培哚普利是一个相对安全的药物。合并陈旧性心肌梗死的心衰患者是发生首剂低血压的易患人群。 Objective To observe the response of first-dose hypotension to 2 mg perindopril and 6.25 mg captopril in patients with chronic heart failure (CHF). Methods A multicentre, randomized, parallel-controlled study was carried out. 167 patients (59-91 years old) with CHF were randomized to receive 2 mg of perindopril (n=89) or 6.25 mg of captopril (n=78). Blood pressure was monitored by ambulatory blood pressure measurement 2 hours before and 8 hours following drug intake. Results The incidence of first-dose hypotension (defined as fall in mean arterial pressure≥20 mm Hg and systolic blood pressure <90 mm Hg) was 10.1% in the perindopril group, significantly lower than that in the captopril group (20.5%, P<0.05). All first-dose hypotensive responses were asymptomatic. Captopril elicited greater mean maximum reduction in SBP compared with perindopril [maximum drop in SBP,(24.9± 17.6)mm Hg vs(19.2±15.7)mm Hg, P=0.026]. One third of the patients in first-dose hypotension group had the history of prior myocardial infarction. The incidence of first-dose hypotension was higher in the patients with prior myocardial infarction than in the patients without the history of myocardial infarction (34.8% vs 12.2%, P<0.01). Conclusions Perindopril caused less first-dose hypotension than captopril in patents with CHF. Perindopril was a safer agent for the treatment of CHF. Patients with CHF associated with prior myocardial infarction are susceptible population for first-dose hypotension.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2004年第4期322-325,共4页 Chinese Journal of Cardiology
关键词 心力衰竭 培哚普利 卡托普利 首剂低血压反应 比较 治疗 Heart failure,congestive Perindopril Hypotension
  • 相关文献

参考文献13

  • 1Remme WJ. Hypotension after first-dose ACE inhibitor administration in heart failure-should doctor stop worrying? Cardiov Drug and Therapy, 2001, 15: 475-477.
  • 2Navookarasu NT, Rahman ARA, Abdullah I, et al. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience. Int J Clin Pract, 1999, 53: 25-30.
  • 3Anthopoulos L, Apostolou T, Bonoris P, et al. Comparative haemodynamic responses to the first dose of short- and long- acting ACE inhibitors in patients with congestive heart failure. Cur Med Res Opinion, 2001, 4: 290-297.
  • 4Portuguese Community Hospital Study Group on Heart Failure. A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure. Cardiov Drug and Therapy, 2001, 15: 501-506.
  • 5Haiat R, Piot O, Gallois H, et al. Blood pressure response to the first 36 hours of heart failure therapy with perindopril verse captopril. France General Hospital National College of Cardiologists. J Cardiovasc Pharmacol, 1999, 33: 953-959.
  • 6Moiseev VS, Tereshchenko SN, Aleksandriia LG, et al.Hypotension followed the first dose of angiotensin converting enzyme inhibitor in patients with heart failure (a multicenter clinical trial ). Ter Arkh, 2001, 73: 61-66.
  • 7Vannan MA, Taylor DJE, Webb-Peploe MM, et al. ACE inhibitors after myocardial infarction may benefit patients with left ventricular dysfunction. BMJ, 1993, 306: 531-532.
  • 8Chinese Cardiac Study Collaborative Group. Oral captopril verse placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet, 1995, 345: 686-687.
  • 9ISIS -4 Collaborative Group. ISIS-4:A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet, 1995, 345: 669-677.
  • 10Borghi C, Ambrosioni E. Survival of Myocardial Infarction Long-term Evaluation -2 Working Partner. Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Lon

同被引文献10

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部